feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs",https://benzinga.com/general/biotech/21/07/22219116/the-daily-biotech-pulse-mercks-disappointing-q2-atreca-falls-on-data-fda-nod-for-viatris-nuvalent,https://j.mp/2TFeJpW
